TRP_1170x120_12-19-19

Larry Merlo

Walgreens, Valeant sign distribution pact

DEERFIELD, Ill. — Walgreens and Valeant Pharmaceuticals International Inc. have inked a distribution deal that will cut prices of Valeant prescription products at Walgreens by 10%, and may be extended to independent retail pharmacies. The discount will apply to wholesale list prices and will be phased in over the next six to nine months. The

CVS takes ownership of Target pharmacies

WOONSOCKET, R.I. — CVS Health Corp. has completed the acquisition of Target Corp.’s pharmacy and clinic businesses, making CVS the No. 1 drug chain by store count and sales. With the closing of the $1.9 billion deal, CVS has picked up Target’s 1,672 pharmacies across 47 states, giving it more than 9,500 prescription counters. Walgreens

CVS well positioned to create value in health care

CVS well positioned to create value in health care

NEW YORK — CVS Health has raised the midpoint of its earnings outlook for 2016 and reiterated its five-year steady state targets. The company now expects next year’s adjusted earnings per share to range from $5.73 to $5.88, reflecting solid year-over-year growth of 11.25% to 14.25%. The bottom end of the range was increased by

CVS closes purchase of Target pharmacies, clinics

CVS closes purchase of Target pharmacies, clinics

WOONSOCKET, R.I., and MINNEAPOLIS — CVS Health has completed its $1.9 billion acquisition of Target Corp.’s pharmacy and retail health clinic business. The companies said Wednesday that Target’s 1,672 pharmacies in 47 states will be branded as CVS/pharmacy and operated under a store-within-a-store format. A CVS/pharmacy will be in all new Target stores that offer

CVS Health’s Merlo: ‘No one is better positioned’

CVS Health’s Merlo: ‘No one is better positioned’

NEW YORK — At its annual Analyst Day event here, CVS Health updated its earnings guidance for 2016 and reiterated its five-year targets. “Over the past several years, CVS Health has been preparing for the changes in the health care landscape by expanding our extensive suite of leading assets and capabilities,” said president and chief

Questions abound as ’15 draws to a close

Questions abound as ’15 draws to a close

The National Association of Chain Drug Stores held its year-end meetings in New York City early this month — and very little was as it had been a year ago. Many of the same familiar faces were on hand, and several of the same retail companies attended. But the yearlong series of events that have

Investment pros: Merlo is top food/drug retail CEO

Investment pros: Merlo is top food/drug retail CEO

Larry Merlo, president and chief executive officer of CVS Health, was named the No. 1 CEO in the food/drug retailing sector by Institutional Investor magazine. Merlo was part of the financial publication’s “2016 All-America Executive Team,” in which more than 2,000 portfolio managers and analysts were asked to name the best CEOs, CFOs and investor

CVS Health reports rise in revenue for 3Q

CVS Health reports rise in revenue for 3Q

WOONSOCKET, R.I. — CVS Health posted sales gains in both its retail pharmacy and pharmacy services businesses for the 2015 third quarter, with adjusted earnings per share (EPS) finishing in line with analysts’ projections. CVS also said Friday that it has expanded its business segments to incorporate operations from the Omnicare Inc. acquisition, which closed

Coming year will be crucial for the industry

Coming year will be crucial for the industry

As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in

CVS Health tallies 2Q sales, earnings gains

CVS Health tallies 2Q sales, earnings gains

WOONSOCKET, R.I. — CVS Health saw sales climb in the second quarter and posted adjusted earnings per share in line with Wall Street’s forecast, despite the impact of costs from its pending Omnicare and Target pharmacy acquisitions. CVS said Tuesday that for the three months ended June 30, total sales rose 7.4% to $37.2 billion from

CVS, Walgreens take part in youth jobs coalition

CVS, Walgreens take part in youth jobs coalition

CHICAGO — CVS Health, Walgreens, Walmart and Target are among more than a dozen U.S.-based companies forming the 100,000 Opportunities Initiative, an employer-led coalition that aims to create pathways to jobs for America’s young people. The coalition has set a goal to engage at least 100,000 “Opportunity Youth” — 16- to 24-year-olds who face systemic

CVS to gain more clout by acquiring Target Rx business

CVS to gain more clout by acquiring Target Rx business

WOONSOCKET, R.I. — Continuing its aggressive growth and diversification, CVS Health has purchased Target Corp.’s pharmacy and clinic businesses for some $1.9 billion. The acquisition propels CVS past Walgreens as the nation’s No. 1 pharmacy operator by market share and store count. CVS will have close to 9,500 prescription counters. Walgreens had 8,232 as of

CVS refuses to be satisfied with status quo

CVS refuses to be satisfied with status quo

It was a very productive spring for CVS Health. Already performing at a level that made it the envy of most other retailers and health care providers, the company took a series of steps in May and June that will increase its chances of success in several burgeoning sectors of the marketplace. The biggest news

Target CEO: CVS deal represents ‘significant shift’

Target CEO: CVS deal represents ‘significant shift’

MINNEAPOLIS — With CVS Health running Target Corp.’s pharmacies and clinics, the discount chain will be better able to focus on providing wellness products and services throughout its stores, according to Target chairman and chief executive officer Brian Cornell. “This exciting partnership represents a significant shift in our business model and will have notable benefits